Wet

EQS-News: Deutsche Postbank Funding Trust III - Annual Report 2023

Retrieved on: 
Freitag, Mai 3, 2024
Suite, Wet, Annual report, Security (finance)

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • Deutsche Postbank Funding Trust III hereby announces that the annual report as of 31st December 2023 pursuant to Section 5:25c of the Netherlands Financial Supervision Act (Wet op het financieel toezicht) is available at: https://investor-relations.db.com/creditors/prospectuses/reports-deutsch...
    Company: Deutsche Postbank Funding Trust III, 1011 Centre Road, Suite 200, 19805-1266 Wilmington, Delaware, United States

VSaaS Market worth $10.7 billion by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Donnerstag, April 18, 2024
Cloud, Smoke, VMS, Wet, Investment, Professional, Wildfire, Urbanization, Intelligence, Motorola Solutions, Photoelectric effect, Access control, Monitor, Cloud computing, Video content analysis, Securitas AB, Securitas, IP, DAC, ADT, Hosting, Algorithm, Safety, Thermography, RMON, Transport, Row, RBAC, Organization, Government, Internet, Commercial, Heat detector, Region, Facial recognition, Anomaly, Economic development, Flame detector, Growth, Storage device, Deep learning, Video game

The VSaaS market for hybrid services is experiencing notable growth due to its ability to offer a flexible and customizable approach to video surveillance.

Key Points: 
  • The VSaaS market for hybrid services is experiencing notable growth due to its ability to offer a flexible and customizable approach to video surveillance.
  • VSaaS market for AI-enabled VSaaS to hold the highest CAGR during the forecast period.
  • The VSaaS market for AI-enabled VSaaS is experiencing rapid growth due to the transformative impact of artificial intelligence on video surveillance capabilities.
  • These players have a strong market presence for VSaaS across various North America, Europe, Asia Pacific, and RoW countries.

VSaaS Market worth $10.7 billion by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Donnerstag, April 18, 2024
Cloud, Smoke, VMS, Wet, Investment, Professional, Wildfire, Urbanization, Intelligence, Motorola Solutions, Photoelectric effect, Access control, Monitor, Cloud computing, Video content analysis, Securitas AB, Securitas, IP, DAC, ADT, Hosting, Algorithm, Safety, Thermography, RMON, Transport, Row, RBAC, Organization, Government, Internet, Commercial, Heat detector, Region, Facial recognition, Anomaly, Economic development, Flame detector, Growth, Storage device, Deep learning, Video game

The VSaaS market for hybrid services is experiencing notable growth due to its ability to offer a flexible and customizable approach to video surveillance.

Key Points: 
  • The VSaaS market for hybrid services is experiencing notable growth due to its ability to offer a flexible and customizable approach to video surveillance.
  • VSaaS market for AI-enabled VSaaS to hold the highest CAGR during the forecast period.
  • The VSaaS market for AI-enabled VSaaS is experiencing rapid growth due to the transformative impact of artificial intelligence on video surveillance capabilities.
  • These players have a strong market presence for VSaaS across various North America, Europe, Asia Pacific, and RoW countries.

Stakes Are High for Regeneron's Eylea HD as Genentech's Vabysmo Continues to Gain Momentum, Prompting Doctors to Weigh Their Options Between Two Industry Titans, According to Spherix Global Insights

Retrieved on: 
Donnerstag, Februar 8, 2024
Ranibizumab, Ophthalmology, RealTime, Medicare, Regeneron Pharmaceuticals, Physician, AMD, Wet, Genentech, HCP, Macular degeneration, Marketing, Patient, Aflibercept, Pharmaceutical industry

Wet AMD poses a particularly severe threat to vision, necessitating treatment with biologic therapies administered in four to twelve-week intervals.

Key Points: 
  • Wet AMD poses a particularly severe threat to vision, necessitating treatment with biologic therapies administered in four to twelve-week intervals.
  • However, the current treatment landscape often burdens elderly patients with high treatment frequencies, impacting their ability to attend all appointments.
  • Spherix Global Insights conducted an in-depth analysis through its RealTime Dynamix™ report series, delving into the evolving perceptions of ophthalmologists (n=101) regarding approved therapies for wet AMD.
  • In January 2024, ophthalmologists were surveyed on their preferred biologic treatment for wet AMD among other topics.

Xpander and Xpander Cross HEV Models Premiere in Thailand, Featuring Safe, Secure and Exhilarating Driving Experience of Electrified Vehicles

Retrieved on: 
Donnerstag, Februar 1, 2024
Diamond, HEV, White Diamond, NEDC, Wet, Growth, Family, Mitsubishi Motors, LCD, Acceleration, Mitsubishi Group, Torque, Torque vectoring, Friends, EV, CO2, Power, Xpander, Mitsubishi Xpander, MIVEC, Weather, Gasoline, Sale, Outlander, Electricity, AYC, New European, CVT

The newly-added HEV models combine Mitsubishi Motors' trademark electrification and all-wheel control technologies to raise the appeal of the Xpander series to another level.

Key Points: 
  • The newly-added HEV models combine Mitsubishi Motors' trademark electrification and all-wheel control technologies to raise the appeal of the Xpander series to another level.
  • Newly developed based on the brand's plug-in hybrid electric vehicles (PHEVs), the HEV system delivers an eco-friendly and exhilarating driving experience unique to electrified vehicles.
  • Moreover, drivers can actively choose EV driving according to the situation, such as driving in quiet residential areas early in the morning.
  • Hybrid driving also kicks in when driving at high speeds to run using the engine with assistance from the motor (Figure 3).

EQS-News: Deutsche Postbank Funding Trust III: Half Year Report as of 30th June 2023

Retrieved on: 
Dienstag, November 7, 2023
News, Netherlands, Wet, Security (finance)

Deutsche Postbank Funding Trust III: Half Year Report as of 30th June 2023

Key Points: 
  • Deutsche Postbank Funding Trust III: Half Year Report as of 30th June 2023
    The issuer is solely responsible for the content of this announcement.
  • Deutsche Postbank Funding Trust III hereby announces that the half year report as of 30th June 2023 pursuant to Section 5:25c of the Netherlands Financial Supervision Act (Wet op het financieel toezicht) is available at: https://investor-relations.db.com/creditors/prospectuses/reports-deutsch...
    01.11.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
  • The issuer is solely responsible for the content of this announcement.
  • The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Teleperformance SE: Final Results of the Offer for Majorel

Retrieved on: 
Freitag, November 3, 2023
Consulting, Professional Services, Outsourcing Business, Disclosure, Electric Bond and Share Company v. Securities and Exchange Commission, Positive statement, Wet, Amendment, EUR, CET, PP, Euronext Amsterdam, ABN, AMRO Bank, Judgement, Euronext Paris, Cash, Market, Person, Bank statement, Position, Article, AMF, Digital, Paragraph, Financial market, Section 17 of the Canadian Charter of Rights and Freedoms, Failure, AFM, Security (finance), Cryptocurrency, Mobile phone, Share (finance), Majorel, Teleperformance, Onafhankelijke Post en Telecommunicatie Autoriteit

This press release does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities in Teleperformance or Majorel.

Key Points: 
  • This press release does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities in Teleperformance or Majorel.
  • A total of 78,984,447 Shares have been tendered against the Share Consideration during the Offer Period and the Post-Acceptance Period.
  • Teleperformance intends to offer the amount of the Cash Consideration (i.e., EUR 30 per Share) as part of these squeeze-out proceedings.
  • Reference is made to Section 6.13 (Consequences of the Offer for non-tendering Shareholders) of the Offer Memorandum.

Teleperformance declares Offer for Majorel unconditional 98.45% of Shares tendered under the Offer – Opening of the Post-Acceptance Period

Retrieved on: 
Freitag, Oktober 20, 2023
Technology, Artificial Intelligence, Other Technology, Bertelsmann, Disclosure, Electric Bond and Share Company v. Securities and Exchange Commission, Closing time effect, Positive statement, Wet, Amendment, EUR, Business Day, CET, Section, PP, Euronext Amsterdam, ABN, AMRO Bank, Acquisition, Judgement, Euronext Paris, Person, Bank statement, Shareholder, Position, Article, AMF, Digital, Closing time, Paragraph, Section 17 of the Canadian Charter of Rights and Freedoms, Business, Failure, AFM, Cryptocurrency, Security (finance), Auction, Mobile phone, Share (finance), Majorel, Teleperformance

As a result, Teleperformance declares the Offer unconditional (doet gestand) and the Post-Acceptance Period will start as from 23 October 2023 for a 2-week period.

Key Points: 
  • As a result, Teleperformance declares the Offer unconditional (doet gestand) and the Post-Acceptance Period will start as from 23 October 2023 for a 2-week period.
  • Shareholders who have elected to receive the Share Consideration during the Offer Period or the Post-Acceptance Period will receive on the Second Settlement Date Teleperformance shares at an exchange ratio of 30/217.
  • Further information on the Post-Acceptance Period is included in Section 5.8 (Post-Acceptance Period) of the Offer Memorandum.
  • A maximum of 4,608,295 Teleperformance shares is available for issue under the Share Consideration, (i.e., a maximum of 33,333,334 Shares can be exchanged for Teleperformance shares).

New Clinical and Real-World Data for Genentech’s Vabysmo at ASRS Reveal Improved Outcomes for People With Two Leading Causes of Vision Loss

Retrieved on: 
Donnerstag, Juli 20, 2023
Biotechnology, Health, Pharmaceutical, Optical, Clinical Trials, Retina, Abstract, DME, ERM, AMD, Anatomy, Paratriathlon, Eye, Neovascularization, Diabetic retinopathy, ROG, RO, Wet, Patient, Data, Ophthalmology, Annual general meeting, United Kingdom, Society, Macular degeneration, ASRS, Update, Roche, Pharmaceutical industry, Medical imaging, Faricimab, Genentech

“The clinical and real-world data at ASRS reinforce the improvement in outcomes brought by Vabysmo in two leading causes of vision loss, particularly new analyses suggesting that Vabysmo is associated with less vision-impacting fibrosis than aflibercept,” said Levi Garraway, M.D., Ph.D., chief medical officer and head of Global Product Development.

Key Points: 
  • “The clinical and real-world data at ASRS reinforce the improvement in outcomes brought by Vabysmo in two leading causes of vision loss, particularly new analyses suggesting that Vabysmo is associated with less vision-impacting fibrosis than aflibercept,” said Levi Garraway, M.D., Ph.D., chief medical officer and head of Global Product Development.
  • Wet AMD and DME are two leading causes of vision loss, together affecting more than two million people in the United States and 40 million people globally.
  • Data will also further support how increased intervals between doses of Vabysmo to treat wet AMD and DME, compared to aflibercept, do not compromise outcomes.
  • Elevatum Study Design and Rationale: A Phase 4 Trial of Faricimab (VABYSMO) in Underrepresented Patients With Diabetic Macular Edema

Alta Copper Appoints Andrew Hamilton to the Board of Directors

Retrieved on: 
Montag, Juli 10, 2023
Magnet, University, Iron Bridge, Bachelor of Engineering, Fortescue Metals Group, Mechanical engineering, African, The Iron Bridge, Tavarua, University of South Australia, Metallurgy, Magnetite, Christmas Creek, Hematite, US, Metal, Wet, Project management, Engineering, Australian Institute of Company Directors, ATCU, Technical director, TSX, BVL, Investment, Project Magnet, Mecha, Construction, Mining

VANCOUVER, British Columbia, July 10, 2023 (GLOBE NEWSWIRE) -- Alta Copper Corp. (TSX: ATCU; OTCQX: ATCUF; BVL: ATCU) (“Alta Copper” or the “Company”) announces the appointment of Mr. Andrew Hamilton as a director of the Company.

Key Points: 
  • VANCOUVER, British Columbia, July 10, 2023 (GLOBE NEWSWIRE) -- Alta Copper Corp. (TSX: ATCU; OTCQX: ATCUF; BVL: ATCU) (“Alta Copper” or the “Company”) announces the appointment of Mr. Andrew Hamilton as a director of the Company.
  • “We are pleased to announce the appointment of Andrew Hamilton to the Board of Directors of Alta Copper.
  • Mr. Andrew Hamilton is Technical Director of Fortescue Metals with the Corporate Strategy Team.
  • Mr. Hamilton held various roles on the US$3.9bn IBJV project including Project Director and Technical Director.